Metrics Masterome Trust (ASX:MXT) Research & Development: A$0.0 Mil (TTM As of Dec. 2025)


ASX:MXT Metrics Master Income Trust ASX:MXT
73 GF Score
Price A$1.91
GF Value A$2.10
Valuation Fairly Valued
! 3 Warning Signs
View Full Analysis

What is Metrics Masterome Trust Research & Development?

Metrics Masterome Trust ASX:MXT +0.26% 73 Research & Development is A$0.0 Mil as of Dec. 2025. GuruFocus rates ASX:MXT with a GF Score™ of 73/100 and a GF Value™ of A$2.10 (Fairly Valued). The stock has 3 warning signs investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. Metrics Masterome Trust's Research & Development for the six months ended in Dec. 2025 was A$0.0 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Dec. 2025 was A$0.0 Mil.

Metrics Masterome Trust  (ASX:MXT) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Metrics Masterome Trust Research & Development Related Terms

Metrics Masterome Trust Research & Development Historical Data

* Premium members only.

The historical data trend for Metrics Masterome Trust's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Metrics Masterome Trust Research & Development Chart

Metrics Masterome Trust Annual Data
Trend Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24 Jun25
Research & Development
Get a 7-Day Free Trial 0.00 0.00 0.00 0.00 0.00

Metrics Masterome Trust Semi-Annual Data
Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
ASX:MXT
73GF Score
Metrics Master Income Trust ASX:MXT
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Metrics Masterome Trust Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was A$0.0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of A$0.0 Mil mean?
Metrics Masterome Trust (ASX:MXT) has a Research & Development of A$0.0 Mil as of Dec. 2025. Research and development expense is the total cost for research and development activities. View historical data on Metrics Masterome Trust and its competitors.
Is Metrics Masterome Trust's Research & Development too high?
Metrics Masterome Trust's current Research & Development is A$0.0 Mil. Overall, Metrics Masterome Trust has a GF Score™ of 73/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Metrics Masterome Trust's Research & Development compare to BLK and BX?
Metrics Masterome Trust's Research & Development of A$0.0 Mil can be compared against companies in the Asset Management industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for an Asset Management company?
A good Research & Development depends on the Asset Management industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on Metrics Masterome Trust and its competitors. Metrics Masterome Trust's current Research & Development is A$0.0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Metrics Masterome Trust stock overvalued right now?
Based on GuruFocus' analysis, Metrics Masterome Trust (ASX:MXT) is currently considered Fairly Valued. The stock's GF Value™ is A$2.10, compared to a current price of A$1.91 — trading 9.3% below its estimated fair value. The current Research & Development is A$0.0 Mil. Metrics Masterome Trust's overall GF Score™ is 73/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For Metrics Masterome Trust (ASX:MXT), the current Research & Development is A$0.0 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Metrics Masterome Trust (ASX:MXT) Overvalued in 2026?

Based on GuruFocus' analysis, Metrics Masterome Trust stock appears to be undervalued. The current stock price of A$1.91 is trading 9.3% below its estimated GF Value™ of A$2.10. GuruFocus considers Metrics Masterome Trust to be Fairly Valued.

Key valuation signals for ASX:MXT:

  • Research & Development: A$0.0 Mil
  • GF Value™: A$2.10 vs. price of A$1.91 (9.3% below fair value)
  • GF Score™: 73/100 with 3 warning signs

No single metric tells the full story. See the ASX:MXT stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Metrics Masterome Trust Business Description

Address 123 Pitt Street, Level 18, Angel Place, Sydney, NSW, AUS, 2000
Metrics Master Income Trust is a non-bank corporate lender and alternative asset manager specialising in fixed income, private credit, equity, and capital markets. It provides service to the Australian private debt market to investors ranging from individuals to institutions.
73GF Score

Get the complete analysis for ASX:MXT

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

A$1.91
Price
A$2.10
GF Value